Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Aflatoxigenicity of Rhizopus nigricans strains isolated from drug plants (CROSBI ID 82719)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Pepeljnjak, Stjepan ; Cvetnić, Zdenka Aflatoxigenicity of Rhizopus nigricans strains isolated from drug plants // Acta pharmaceutica, 48 (1998), 2; 1139-144-x

Podaci o odgovornosti

Pepeljnjak, Stjepan ; Cvetnić, Zdenka

engleski

Aflatoxigenicity of Rhizopus nigricans strains isolated from drug plants

Mycological analyses of 64 samples of drug plants stored and collected from drugstores showed 50% of samples to be contaminated with Rhizopus nigricans. Aflatoxigenicity of Rhizopus nigricans strains was assessed by specific fluorescence test in aflatoxin-producing ability medium (APA) (detection in UV at 365 nm) and by extraction after biosynthesis on yeast extract sucrose (YES) broth. Aflatoxins were produced by 40% of strains. All of the aflatoxins-producing strains in YES showed intensive blue fluorescence in the APA medium. The strains of Rhizopus nigricans were producers of two aflatoxins :AFLB1 and AFLB2. The concentrations of aflatoxin B1 and aflatoxinB2 ranged from 1.22 to 1.33 and from 0.1 to 0.2 mg/L culture filtrate, respectively. The results warn of the risk of improper storing and using drug plants with no previous evaluation of their quality in terms of mycotoxicological parameters.

Mycological contamination; drug plants; Rhizopus nigricans; Aflatoxin B1; Aflatoxin B2

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

48 (2)

1998.

1139-144-x

objavljeno

1330-0075

Povezanost rada

Javno zdravstvo i zdravstvena zaštita

Indeksiranost